TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al > Summary
Court Case Number 3:21-cv-13240
Filing Date Jul 1, 2021
Termination Date Jun 10, 2022
Court New Jersey District Court
Status Dismissed - Settled
JudgesFreda L. Wolfson, Douglas E. Arpert, Rukhsanah L. Singh
Plaintiff Attorneys
13TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Katelyn O'Reilly
Walsh Pizzi O’Reilly Falanga LLP
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: William T. Walsh Jr.
Walsh Pizzi O’Reilly Falanga LLP
AUSPEX Pharmaceuticals (Teva)
Attorney Name: Katelyn O'Reilly
Walsh Pizzi O’Reilly Falanga LLP
AUSPEX Pharmaceuticals (Teva)
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
AUSPEX Pharmaceuticals (Teva)
Attorney Name: William T. Walsh Jr.
Walsh Pizzi O’Reilly Falanga LLP
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: David L Bernard III
Williams & Connolly
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Julie L. Tavares
Williams & Connolly
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Thomas S. Fletcher
Williams & Connolly
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Attorney Name: Michaela Wilkes Klein
Williams & Connolly
Attorney Name: David I. Berl
Attorney Name: David I. Berl
Defendant Attorneys
7Aurobindo Pharma USA
Attorney Name: R. Touhey Myer
Kratz & Barry
Aurobindo Pharma
Attorney Name: R. Touhey Myer
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Karen A. Confoy
Fox Rothschild
Aurobindo Pharma USA
Attorney Name: Timothy H. Kratz
Kratz & Barry
Attorney Name: Michael P. Hogan
Attorney Name: Michael P. Hogan
Attorney Name: Paul W. Kalish
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11179386 | Analogs of deutetrabenazine, their preparation and use | Nov 23, 2021 |
| 10959996 | Methods for the treatment of abnormal involuntary movement disorders | Mar 30, 2021 |
| 09814708 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Nov 14, 2017 |
| 09550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Jan 24, 2017 |
| 09296739 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Mar 29, 2016 |
| 09233959 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | Jan 12, 2016 |
| 08524733 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | Sep 3, 2013 |
